RENOVARO INC. - COMMON STOCK
0.5321
31-October-24 14:59:59
15 minutes delayed
Stocks
-0.0079
-1.46%
Today's range
0.5321 - 0.5998
ISIN
N/A
Source
NASDAQ
-
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
02 Oct 2023 08:25:00 By Nasdaq GlobeNewswire
-
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
29 Sep 2023 08:15:00 By Nasdaq GlobeNewswire
-
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
30 Aug 2023 08:15:00 By Nasdaq GlobeNewswire
-
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
21 Aug 2023 08:15:00 By Nasdaq GlobeNewswire
-
09 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
23 Jun 2023 16:00:00 By Nasdaq GlobeNewswire
-
08 Jun 2023 07:45:00 By Nasdaq GlobeNewswire
-
Enochian BioSciences’ CEO Letter to Shareholders
03 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
13 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
23 Feb 2023 15:04:00 By Nasdaq GlobeNewswire
-
30 Nov 2022 16:20:12 By Nasdaq GlobeNewswire
-
Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
24 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
21 Oct 2022 16:00:00 By Nasdaq GlobeNewswire
-
Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
17 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor
25 Jul 2022 09:15:16 By Nasdaq GlobeNewswire
-
Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data
01 Jul 2022 16:00:00 By Nasdaq GlobeNewswire
-
Scientific Leaders Agree on Promise of Enochian BioSciences
31 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
25 May 2022 15:20:30 By Nasdaq GlobeNewswire
-
20 Apr 2022 06:00:01 By Nasdaq GlobeNewswire